OlegAlbinsky / iStockphoto.com
A decision by the US Supreme Court yesterday will mean no change to the long-standing rules that apply to the “on-sale” bar, but may reduce the incentive for inventors to carry out confidential sales of their inventions, lawyers have told WIPR.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at email@example.com
US Supreme Court, Helsinn Healthcare, Teva, America Invents Act, patent infringement, confidentiality agreement, on-sale bar